Current Assets
Contract Assets, Net
Abbott Contract Assets, Net decreased by 13.1% to $146.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 13.1%, from $168.00M to $146.00M. Over 4 years (FY 2021 to FY 2025), Contract Assets, Net shows a downward trend with a -3.6% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryEfficiency
SignalContext dependent
VolatilityModerate
First reportedQ4 2023
Last reportedQ3 2025
How to read this metric
An increase indicates significant progress on contracts that will eventually be billed, while a decrease may signal successful billing or project completion.
Detailed definition
This represents the company's right to consideration for goods or services already transferred to a customer, where the...
Peer comparison
Common in industries with long-term construction, defense, or aerospace contracts where billing is milestone-based.
Metric ID:
contract_assets_netHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $169.00M | $187.00M | $198.00M | $168.00M | $146.00M |
| QoQ Change | — | +10.7% | +5.9% | -15.2% | -13.1% |
| YoY Change | — | +10.7% | +5.9% | -15.2% | -13.1% |
Range$146.00M – $198.00M
CAGR-13.6%
Avg YoY Growth-2.9%
Median YoY Growth-3.6%
Current Streak2 quarters decline
Contract Assets, Net at Other Companies
Frequently Asked Questions
- What is Abbott's contract assets, net?
- Abbott (ABT) reported contract assets, net of $146.00M in Q4 2025.
- How has Abbott's contract assets, net changed year-over-year?
- Abbott's contract assets, net decreased by 13.1% year-over-year, from $168.00M to $146.00M.
- What is the long-term trend for Abbott's contract assets, net?
- Over 4 years (2021 to 2025), Abbott's contract assets, net has grown at a -3.6% compound annual growth rate (CAGR), from $169.00M to $146.00M.
- What does contract assets, net mean?
- The value of work performed for customers that has not yet been billed because payment conditions have not been met.